Studies have demonstrated that ZYIL1 is highly potent and can suppress inflammation caused by NLRP3 inflammasome activation
The products are slated to be manufactured at the Ankleshwar facility and is expected to start contributing meaningfully to the revenue from FY25
The product will be manufactured at Lupin's Pithampur facility in India
C-CAR031 is based on a novel GPC3-targeting CAR-T (AZD5851) designed by AstraZeneca using their transforming growth factor-beta receptor II
The esteemed duo perfectly embody the brand's core values of family, love, and the special bond we share with our pets
Carmot Therapeutics’s R&D portfolio of clinical stage incretins has great potential to treat obesity, diabetes and potentially other diseases
The new ECO grade is made using renewable feedstock
The workshop is specially curated for Ayurvedic medical officers from Delhi and Haryana
Global Ayurveda Festival organising in Thiruvananthapuram from 1st to 5th December
South Asia’s largest Trade Fair for pharma brought together over 50,000 visitors from across the globe, more than 1,500 exhibitors showcasing 10,000+ products and representation from over 80 countries
Subscribe To Our Newsletter & Stay Updated
